Having the kind of medicine that manages diabetes and promotes weight loss at the same time is a true breakthrough in this age of modern medicine. But even as we continue to celebrate the huge strides made by pharmaceutical companies in finding possible cures to common diseases we face in our daily lives, we expect these companies to observe high levels of integrity. Sadly, that has not been the case with a few manufacturers like Novo Nordisk and Eli Lilly, the brains behind a series of popular medicines used to treat Type 2 diabetes and promote weight loss.
Recent reports have shown that many people have suffered gastrointestinal diseases from constantly using popular medicines for diabetes and weight loss. Among the medicines mentioned in the reports include Ozempic, Saxenda, Mounjaro, Wegovy, and Rybelsus.
While these products have known side effects, such as headache, fatigue, and dizziness, it is now emerging that their manufacturers did not come clean about other side effects.
For context, several users of these products have been diagnosed with gastrointestinal side effects. The most common is gastroparesis, also known as “paralyzed stomach.”
As the name implies, this condition makes the stomach unable to process food. As a result, some users have fallen violently ill, while some have been hospitalized due to the adverse side effects of these medicines. If you or a loved one has experienced these side effects or anything similar, please tell us about your case. Together, we might be able to hold the manufacturer responsible.